1. Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
- Author
-
Di Rocco, Maja, primary, Forleo-Neto, Eduardo, additional, Pignolo, Robert J., additional, Keen, Richard, additional, Orcel, Philippe, additional, Funck-Brentano, Thomas, additional, Roux, Christian, additional, Kolta, Sami, additional, Madeo, Annalisa, additional, Bubbear, Judith S., additional, Tabarkiewicz, Jacek, additional, Szczepanek, Małgorzata, additional, Bachiller-Corral, Javier, additional, Cheung, Angela M., additional, Dahir, Kathryn M., additional, Botman, Esmée, additional, Raijmakers, Pieter G., additional, Mukaddam, Mona Al, additional, Tile, Lianne, additional, Portal-Celhay, Cynthia, additional, Sarkar, Neena, additional, Hou, Peijie, additional, Musser, Bret J., additional, Boyapati, Anita, additional, Mohammadi, Kusha, additional, Mellis, Scott J., additional, Rankin, Andrew J., additional, Economides, Aris N., additional, Trotter, Dinko Gonzalez, additional, Herman, Gary A., additional, O’Meara, Sarah J., additional, DelGizzi, Richard, additional, Weinreich, David M., additional, Yancopoulos, George D., additional, Eekhoff, E. Marelise W., additional, and Kaplan, Frederick S., additional
- Published
- 2023
- Full Text
- View/download PDF